References
- Hall WD, Saunders E, Shulman NB. Hypertension in Blacks. Year Book Medical Publishers, Chicago, Illinois 1985
- Thorns J, Semenya K, Thomas CB, Thomas DJ, Neser WB, Pearson TA, Gillum RF. Precursors of hypertension in black compared to white medical students. J Chron Dis 1987; 40: 721–727
- Thomas J, Neser WB, Thomas DJ, Semenya K, Green D. R. Precursors of hypertension. J N M A 1983; 75: 359–369
- Veterans Administration Cooperative Study Group on Antihypertensive Agents: Efficacy of Nodolal alone and combined with Bendroflumethiazide and Hydralazine for Systemic Hypertension. Am J Cardiol 1983; 52: 1230–1237
- Saftlas AF, Olsen DR, Franks AL, Atrash HK, Pokras R. Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. Am J Obstet Gynecol 1990; 163: 460–465
- Saunders E. Hypertension in blacks. Med Clin North America 1987; 71: 1013–1029
- Kaunitz JG, Hughes JM, Grimes DA, et al. Causes of maternal mortality in the United States. Obestet Gynecol 1985; 65: 605
- Chesley LC. Hypertensive disorders in pregnancy. Applenton-Century-Crofts, New York 1978
- Pettinger WA, Sanchez A, Saavedra J, Haywood JR, Gandler T, Rodes T. Altered renal alpha-2 adrenergic receptor regulation in genetically hypertensive rats. Hyperten 1982; 4-II: 188–192
- Woodcock EA, Johnston CI. Changes in tissue alpha and beta-adrenergic receptors in renal hypertension in the rat. Hyperten 1980; 2: 156–161
- Bock KD, Brodde O, Daul A, O'Hara N. Increased density and responsiveness of alpha-2 and beta-adrenoceptors in circulating blood cells of essential hypertensive patients. J Hyperten 1984; 2: 111–114
- Coutinsouza-Blanc D, Dausse J, Elghozi J. Alteration of platelet alpha -adrenoceptors in human hypertension. J hyperten 1984; 2: 155–157
- Insel PA, Motulsky HJ, O'Conner DT. Platelet alpha-2 adrenergic receptors in treated and untreated essential hypertension. Clin Sci 1983; 64: 265–272
- Bjornsson S, Cameron AD, Fraser C, Singer CRJ, Walker JJ. Can platelet volume predict progressive hypertensive disease in pregnancy?. Am J Obstet Gyn 1989; 161: 676–679
- Brodde O-E, Daul A, O'Hara N, Bock KD. Increased density and responsivness of alpha-2 and beta- adrenoceptors in circulating blood cells of essential hypertensive patients. J Hyperten 1984; 2: 111–114, suppl.3
- Boon NA, Elliot JM, Davis CL, Conway FJ, Vones JV, Grahame-Smith D. G., Sleight P. Platelet alpha-adrenoceptors in borderline and established essential hypertension. Clin Sci 1983; 65: 207–208
- Motulsky HJ, O'Connor DT, Insel PA. Platelet alpha-2 adrenergic receptors in treated and untreated essential hypertension. Clin Sci 1983; 64: 265–272
- Roberts JM, Lewis V, Mize N, Tsuchiya A, Starr J. Human platelet alpha-adrenergic receptors and responses during pregnancy, No change except that with differing hematocrit. Am J Obstet Gynecol 1986; 154: 206–210
- Anderson S, Graham RM, Brater DC. Differences in response of black hypertensives to alpha vs. beta adrenergic antagonists. Am J Med Sci 1985; 290: 15–18
- Garcia-Sevilla JA, Hollingsworth PJ, Smith CB. Alpha-2 adrenoreceptors on human platelets: selective labelling by [3H]clonidine and [3H]yohimbine and competitive inhibition by antidepressant drugs. Euro J Pharmacol 1981; 74: 329–341
- Scatchard G. The attractions of proteins for small molecules and ions. Ann NY Acad Sci 1949; 51: 660–672
- Metha J, Metha P. Platelet function in hypertension and effect of therapy. Am J Card 1981; 47: 331–334
- Morrison R, Crawford J, MacPherson M, Heptinstall S. Platelet behaviour in normal pregnancy, pregnancy complicated by essential hypertension and pregnancy-induced hypertension. Thromb Haemostas 1985; 54(3)607–611
- Lefkowitz RJ. Clinical physiology of adrenergic receptor regulation. Am J Physiol 1982; 243: E43–E47